Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in Vivo

相似書籍

• PPARγ2 NUCLEAR RECEPTOR CONTROLS MULTIPLE REGULATORY PATHWAYS OF OSTEOBLAST DIFFERENTIATION FROM MARROW MESENCHYMAL STEM CELLS
  由: Shockley, Keith R., et al.
  出版: (2009)
• Strain-Specific Effects of Rosiglitazone on Bone Mass, Body Composition, and Serum Insulin-Like Growth Factor-I
  由: Ackert-Bicknell, Cheryl L., et al.
  出版: (2009)
• Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator activated receptor-γ (PPAR-γ)-deficient mice
  由: Duan, S. Z., et al.
  出版: (2010)
• Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2)
  由: Stechschulte, Lance A., et al.
  出版: (2016)
• Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2).
  由: Stechschulte, Lance A., et al.
  出版: (2018)